A phase II, open‐label study to assess safety and clinical utility of 68Ga‐THP‐PSMA PET/CT in patients with high‐risk primary prostate cancer or biochemical recurrence after radical treatment
Year: 2020
Type: article
Study design: Clinical Trial
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3161244090
